Medivation (MDVN) Misses Q1 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Medivation (MDVN) Misses Q1 EPS by 10c

Medivation Reports First Quarter 2015 Financial Results

May 7, 2015 4:10 PM EDT

SAN FRANCISCO, CA -- (Marketwired) -- 05/07/15 -- Medivation, Inc. (NASDAQ: MDVN) today reported its financial results for the first quarter ended March 31, 2015. U.S. net sales of XTANDI (enzalutamide) capsules, as reported by Astellas Pharma Inc., were $224.0 million for the quarter (+80% vs. prior year). On its February 25, 2015 earnings call, Medivation stated its expectation that first quarter U.S. net sales may be at or below fourth quarter 2014 net sales of $230.2 million. First quarter U.S. net sales of $224.0 million were driven by an increase in underlying demand (low teens percent) offset by an anticipated... More